Medication

Rep. Anna Eshoo, D-Calif., right, chair of the House Health Subcommittee, says President Donald Trump and Attorney General William Barr want to take a sledgehammer to health care, as she joins, from left, Rep. Lisa Blunt Rochester, D-Del., House Speaker Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., at a Democratic event ahead of a House floor vote on the Health Care and Prescription Drug Package, at the Capitol in Washington, Wednesday, May 15, 2019. (AP Photo/J. Scott Applewhite)
May 16, 2019 - 7:07 pm
WASHINGTON (AP) — Democrats pushed legislation buttressing the 2010 health care law and curbing prescription drug prices through the House Thursday, advancing a bill that has no chance of surviving in the Senate or getting President Donald Trump's signature and seemed engineered with next year's...
Read More
FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices. (AP Photo/Susan Walsh, File)
May 08, 2019 - 9:01 am
WASHINGTON (AP) — Those ever-present TV ads for prescription drugs will soon carry prices, too, the nation's top health official said Wednesday, responding to a public outcry for government action to restrain medication costs. Health and Human Services Secretary Alex Azar said the Trump...
Read More
In this Friday, April 26, 2019 photo, a box of RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc. reports financial results Tuesday, April 30. (AP Photo/Wilfredo Lee)
April 30, 2019 - 2:27 pm
Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit expectations. Investors drove up Pfizer shares $1.20, or 3%, to $40.79 in early afternoon trading. Sales of breast cancer drug Ibrance and...
Read More
FILE - In this Jan. 30, 2019 file photo, employees prune marijuana plants at a Fotmer SA, greenhouse in Nueva Helvecia, Uruguay. On April 24, 2019, Fotmer in Uruguay and another company in Colombia announced they will become the first to export legal medical marijuana products from Latin America to Europe, part of what the firms hope will become a growing trade. (AP Photo/Matilde Campodonico, File)
April 24, 2019 - 8:41 pm
MONTEVIDEO, Uruguay (AP) — Two companies from Uruguay and Colombia will become the first in Latin America to export medical marijuana products to Europe under deals announced Wednesday. Fotmer Life Sciences of Uruguay and Clever Leaves of Colombia will export cannabis extract and dried marijuana...
Read More
April 16, 2019 - 10:34 am
PROVIDENCE, R.I. (AP) — Drugstore chain CVS Health has agreed to pay $535,000 to resolve federal allegations that it filled dozens of Percocet prescriptions its pharmacists should have known were forged. The U.S. attorney for Rhode Island and the head of the Drug Enforcement Administration's New...
Read More
FILE - This Friday, Oct. 10, 2008, file photo illustration shows Johnson & Johnson products, in Philadelphia. Johnson & Johnson is topping profit and revenue expectations for the first quarter partially on strong sales of its psoriasis treatment, Stelara. The New Brunswick, N.J., company on Tuesday, April 16, 2019 posted profit of $3.75 billion, or $1.39 per share. Earnings, adjusted for amortization costs and research and development costs, were $2.10 per share, or 7 cents better that Wall Street expected, according to a survey by Zacks Investment Research. (AP Photo/Matt Rourke, File)
April 16, 2019 - 7:04 am
Lower sales overseas and higher costs for research and litigation pushed Johnson & Johnson's first-quarter profit down 14%, but the health care giant still beat profit and revenue expectations. The maker of Tylenol and psoriasis drug Stelara on Tuesday said unfavorable currency exchange rates...
Read More
In this April 11, 2019 photo, Shelley Gillen is photographed in her Bellevue, Neb., home with her 17-year-old son, Will, who wears a helmet to protect him from damage during debilitating seizures. Gillen advocates the legalization of medical marijuana that could help her son's seizures. Nebraska's conservative lawmakers are poised to once again reject measures calling for allowing limited and highly regulated use of medical marijuana, but their decision this year could have the unintended consequence of ushering in one of the most unrestricted medical marijuana laws in the country. (AP Photo/Nati Harnik)
April 15, 2019 - 12:18 pm
LINCOLN, Neb. (AP) — Year after year, Nebraska's conservative lawmakers have rejected measures calling for limited and highly regulated medical marijuana. They're poised to do it again, but their decision this year could have the unintended consequence of ushering in one of the most unrestricted...
Read More
FILE - In this Monday, Sept. 24, 2018 file photo, a patient undergoes dialysis at a clinic in Sacramento, Calif. Results of a study released on Sunday, April 14, 2019 show that the diabetes drug Invokana has been shown to help prevent or delay worsening of kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive. (AP Photo/Rich Pedroncelli)
April 14, 2019 - 7:08 pm
A new study shows that a drug used to help control blood sugar in people with diabetes also can prevent or slow kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive. Doctors say it's hard to overstate the importance of...
Read More
FILE - This Aug. 29, 2018, file photo shows an arrangement of prescription oxycodone pills in New York. U.S. health officials Tuesday, April 9. 2019, warned doctors not to abruptly stop prescribing opioid painkillers to patients who are taking them for chronic pain ailments, such as backaches. (AP Photo/Mark Lennihan, File)
April 09, 2019 - 6:05 pm
WASHINGTON (AP) — U.S. health officials Tuesday warned doctors not to abruptly stop prescribing opioid painkillers to patients who are taking them for chronic pain ailments, such as backaches. The Food and Drug Administration said it will add advice to labels on how to taper opioid painkillers,...
Read More
Prime Therapeutics Senior Vice President, General Counsel, and Interim President and Chief Executive Officer Mike Kolar, right, testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9, 2019, during a hearing to explore the high cost of prescription drugs. He is joined at the table by, from left, Cigna Corporation Executive Vice President and Chief Clinical Officer Steve Miller, CVS Caremark President and CVS Health Executive Vice President Derica Rice, Humana Healthcare Services Segment President William Fleming and OptumRx Chief Executive Officer John Prince. (AP Photo/Susan Walsh)
April 09, 2019 - 1:29 pm
Patient bills, competition and secrecy shared the spotlight Tuesday as pharmacy benefit managers testified before Congress about prescription drug prices. Members of a Senate Finance Committee investigating drug costs pushed the benefit managers to explain why they can't do more to control prices...
Read More

Pages